نتایج جستجو برای: lymphoma therapy

تعداد نتایج: 741717  

2017
Akashi Fujita Masahiro Tajika Tsutomu Tanaka Makoto Ishihara Yutaka Hirayama Nobumasa Mizuno Kazuo Hara Susumu Hijioka Hiroshi Imaoka Tsukasa Yoshida Nozomi Okuno Nobuhiro Hieda Takashi Hirayama Hitoshi Shibuya Hisashi Kondo Hirotaka Suzuki Kazuhiro Toriyama Yasushi Yatabe Kenji Yamao Yasumasa Niwa

API2-MALT1 translocation-positive gastric marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT) lymphoma is thought to transform to diffuse large B-cell lymphoma (DLBCL) rarely. A 69-year-old man presented with epigastralgia. Esophagogastroduodenoscopy showed multiple ulcerations in the stomach. Endoscopic biopsies revealed MALT lymphoma, with Helicobacter pylori infection. The pa...

Journal: :Annals of the Academy of Medicine, Singapore 1998
H Y Lau E T Chua T L Yang E J Chua

Orbital lymphoma is a rare presentation of non-Hodgkin's lymphoma. Treatment with radiotherapy is well-established. Twenty cases of orbital lymphoma treated at the Singapore General Hospital with radiation therapy were reviewed. All patients had improvement of their initial presenting symptoms and complete remission after radiation. Long-term local control was achieved in 17 of 20 (85%) of the ...

2016
Eiko Ohya Minoru Mizutani Haruna Sakaguchi Takao Sekine

Thrombocytopenia, anasarca, myelofibrosis, renal dysfunction and organomegaly (TAFRO) syndrome is a variant of Castleman's disease recently identified in Japan. A 73-year-old man was diagnosed with TAFRO syndrome according to clinical findings, and his symptoms improved after corticosteroid therapy. Ten months later, lymphadenopathy worsened during tapering of corticosteroids. Histological find...

2012
Shundong Cang Nikhil Mukhi Kemeng Wang Delong Liu

Rituximab (RTX), a monoclonal antibody (mAb) against CD20, has been widely used for lymphoma therapy. RTX in combination with cyclophosphamide /doxorubicin /vincristine /prednisone (R-CHOP) remains the standard frontline regimen for diffuse large B-cell lymphoma. However, suboptimal response and /or resistance to rituximab have remained a challenge in the therapy of B-cell non-Hodgkin's lymphom...

Journal: :Journal of pediatric hematology/oncology 2013
Paola Zangari Veronica Santilli Nicola Cotugno Emma Manno Giuseppe Palumbo Alessandra Lombardi Rita De Vito Hyppolite Tchidjou Stefania Baldassari Paola Ariganello Giuseppe Pontrelli Francesca De Florio Paolo Palma Stefania Bernardi

Human immunodeficiency virus (HIV) chronically infected patients are at increased risk of developing non-Hodgkin lymphoma compared with the general population. Highly active antiretroviral therapy has had a dramatic effect on the natural history of HIV infection, reducing the incidence of acquired immunodeficiency syndrome-related non-Hodgkin lymphoma and improving overall survival. However, pr...

2017
Yoshinobu Maeda Hisakazu Nishimori Isao Yoshida Yasushi Hiramatsu Masatoshi Uno Yasufumi Masaki Kazutaka Sunami Taro Masunari Yuichiro Nawa Hiromichi Yamane Hiroshi Gomyo Tsutomu Takahashi Tomofumi Yano Keitaro Matsuo Koichi Ohshima Shigeo Nakamura Tadashi Yoshino Mitsune Tanimoto

The standard CHOP therapy for peripheral T-cell lymphoma has resulted in unsatisfactory outcomes and it is still not clear what is the optimal front-line therapy. We conducted a multicenter phase II study of dose-adjusted etoposide, doxorubicin, and cyclophosphamide with vincristine and prednisone (EPOCH) for untreated peripheral T-cell lymphoma patients. In this prospective study, 41 patients ...

2011
Regina S. Offodile Veronica Arce Jessica Cross Jarvis Reed Derrick J. Beech

Localized primary breast lymphoma is very rare. The typical clinical and radiographic presentation of isolated primary breast lymphoma mimics that of breast adenocarcinoma. Histologic diagnosis of primary breast lymphoma relies heavily on Hematoxylin and Eosin pathologic evaluation and immunohistochemical staining. Cytotoxic systemic chemotherapy is the primary treatment for this disease with t...

2013
Yuan Fu Huayuan Zhu Peng Liu

Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma (WM/LPL) is a low-grade B-cell non-Hodgkin's lymphoma with an indolent clinical course. Higher-grade non-Hodgkin lymphoma (NHL) and therapy-related myelodysplasia/acute leukemia (t-MDS/AML) have been reported in patients with WM/LPL in previous studies. However, only two cases with WM/LPL were reported to develop to Hodgkin lymphoma (HL...

Journal: :Hematological Oncology 2023

Introduction: Previous reviews of phase 1 trials in oncology have reported a treatment response rate 4%–6% and toxicity-related mortality 0.5%. These results may not reflect current Phase trial rates for patients with lymphoma. Methods: All non-pediatric relapsed or refractory (R/R) lymphoma approved by the Cancer Therapy Evaluation Program Institut Gustave Roussy between 2008 2023 (cut-off dat...

2009
Siao-Yi Wang Suresh Veeramani Emilian Racila Jeffrey Cagley David C. Fritzinger Carl-Wilhelm Vogel William St John George J. Weiner

Growing evidence indicates antibodydependent cellular cytotoxicity (ADCC) contributes to the clinical response to monoclonal antibody (mAb) therapy of lymphoma. Recent in vitro analysis suggests C3b can inhibit mAb-induced natural killer (NK)–cell activation and ADCC. Further studies were conducted to assess the effect of C3 depletion on mAbinduced NK activation and therapy of lymphoma. Normal ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید